AU2002212292A1 - Extracellular polypeptides of eph b receptors and ephrin b ligands and the corresponding nucleic acid molecules - Google Patents

Extracellular polypeptides of eph b receptors and ephrin b ligands and the corresponding nucleic acid molecules

Info

Publication number
AU2002212292A1
AU2002212292A1 AU2002212292A AU1229202A AU2002212292A1 AU 2002212292 A1 AU2002212292 A1 AU 2002212292A1 AU 2002212292 A AU2002212292 A AU 2002212292A AU 1229202 A AU1229202 A AU 1229202A AU 2002212292 A1 AU2002212292 A1 AU 2002212292A1
Authority
AU
Australia
Prior art keywords
ephrin
eph
ligands
receptors
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212292A
Inventor
Gene Liau
Jeanette Marjorie Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2002212292A1 publication Critical patent/AU2002212292A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002212292A 2000-09-29 2001-09-28 Extracellular polypeptides of eph b receptors and ephrin b ligands and the corresponding nucleic acid molecules Abandoned AU2002212292A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1910/00 2000-09-29
CH19102000 2000-09-29
PCT/EP2001/011252 WO2002026827A1 (en) 2000-09-29 2001-09-28 Extracellular polypeptides of eph b receptors and ephrin b ligands and the corresponding nucleic acid molecules

Publications (1)

Publication Number Publication Date
AU2002212292A1 true AU2002212292A1 (en) 2002-04-08

Family

ID=4566752

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212292A Abandoned AU2002212292A1 (en) 2000-09-29 2001-09-28 Extracellular polypeptides of eph b receptors and ephrin b ligands and the corresponding nucleic acid molecules

Country Status (2)

Country Link
AU (1) AU2002212292A1 (en)
WO (1) WO2002026827A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6864227B1 (en) 1998-04-13 2005-03-08 California Institute Of Technology Artery-and vein-specific proteins and uses therefor
US6887674B1 (en) 1998-04-13 2005-05-03 California Institute Of Technology Artery- and vein-specific proteins and uses therefor
CA2452578A1 (en) * 2001-07-03 2003-01-16 The Hospital For Sick Children Ephrin and eph receptor mediated immune modulation
AU2002951409A0 (en) 2002-09-16 2002-09-26 North Western Adelaide Health Services Methods for regulating cancer
WO2004028551A1 (en) 2002-09-24 2004-04-08 The Burnham Institute Novel agents that modulate eph receptor activity
AU2004210463B2 (en) * 2003-02-07 2009-07-16 Ludwig Institute For Cancer Research Limited Eph/ephrin mediated modulation of cell adhesion and tumour cell metastasis
AU2003900541A0 (en) * 2003-02-07 2003-02-20 Ludwig Institute For Cancer Research Modulation of cell adhesion and tumour cell metastasis
US7381410B2 (en) 2003-03-12 2008-06-03 Vasgene Therapeutics, Inc. Polypeptide compounds for inhibiting angiogenesis and tumor growth
EP1605961A4 (en) 2003-03-12 2009-11-11 Vasgene Therapeutics Inc Polypeptide compounds for inhibiting angiogenesis and tumor growth
CN1921892A (en) * 2003-10-17 2007-02-28 艾克蒂斯生物公司 Lentiviral vector delivery of msp36 for treatment of cancer
EP1526380A1 (en) * 2003-10-21 2005-04-27 Progenika Biopharma, S.A. Methods for in vitro diagnosis and in vitro prognosis of cancer of the pancreas and for the development of drugs against cancer of the pancreas
CN1980573A (en) * 2003-12-31 2007-06-13 艾克蒂斯生物公司 Lentiviral vector delivery of native and mutated IGFBP-3 for treatment of cancer
JP4960859B2 (en) 2004-03-12 2012-06-27 バスジーン セラピューティクス，インコーポレイテッド Polypeptide compounds for inhibiting angiogenesis and tumor growth
CN102746401A (en) 2004-03-12 2012-10-24 瓦斯基因治疗公司 Polypeptide compound for inhibiting angiogenesis and tumor growth
US20090042778A1 (en) * 2004-04-05 2009-02-12 Aqumen Biopharmaceuticals K.K. Methods for Suppressing Neovascularization Using Ephrinb2
EP1745073A2 (en) * 2004-05-14 2007-01-24 Receptor Biologix, Inc. Cell surface receptor isoforms and methods of identifying and using the same
ES2529451T3 (en) 2004-09-23 2015-02-20 Vasgene Therapeutics, Inc. Polypeptide compounds to inhibit angiogenesis and tumor growth
JP2008528614A (en) * 2005-01-27 2008-07-31 ザ・バーンハム・インスティテュート EphB receptor binding peptide
WO2007005244A1 (en) * 2005-07-05 2007-01-11 The Regents Of The University Of California Henipavirus receptor and uses thereof
WO2007043629A1 (en) * 2005-10-05 2007-04-19 Aqumen Biopharmaceuticals K.K. Method of inhibiting angiogenesis by using ephrin b2
JP2009221107A (en) * 2006-05-24 2009-10-01 Aqumen Biopharmaceuticals Kk Peptide enhancing ephrin b2 activity, its salt, medicinal composition and kit for treating
CN102083861B (en) 2007-08-13 2016-04-13 瓦斯基因治疗公司 Use the cancer therapy in conjunction with the humanized antibody of EphB4

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0669929T3 (en) * 1992-11-13 2007-01-29 Immunex Corp Elk ligand, a cytokine
US6303769B1 (en) * 1994-07-08 2001-10-16 Immunex Corporation Lerk-5 dna
US5624899A (en) * 1994-07-20 1997-04-29 Genentech Inc. Method for using Htk ligand
WO1996026958A2 (en) * 1995-02-27 1996-09-06 President And Fellows Of Harvard College Eph RECEPTOR LIGAND ELF-2
WO1999017796A2 (en) * 1997-10-02 1999-04-15 Leukosite, Inc. Modulation of lerk-2-mediated cell adhesion
ATE293989T1 (en) * 1998-11-20 2005-05-15 Genentech Inc USE OF EPH RECEPTOR ANTAGONISTS AND AGONISTS FOR THE TREATMENT OF VASCULAR DISEASES

Also Published As

Publication number Publication date
WO2002026827A1 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
AU2002212292A1 (en) Extracellular polypeptides of eph b receptors and ephrin b ligands and the corresponding nucleic acid molecules
AU2002366951A1 (en) Novel nucleic acids and polypeptides
AU2002326877A1 (en) Novel nucleic acids and polypeptides
AU2002314709A1 (en) Novel nucleic acids and polypeptides
AU2002353923A1 (en) Bgl5 beta-glucosidase and nucleic acids encoding the same
AU2002362592A1 (en) Bgl3 beta-glucosidase and nucleic acids encoding the same
AU2002356869A1 (en) Bgl4 beta-glucosidase and nucleic acids encoding the same
AU2002357681A1 (en) Egvii endoglucanase and nucleic acids encoding the same
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001234944A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001296235A1 (en) Novel nucleic acids and polypeptides
AU2001268028A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2001265311A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
AU2002216610A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2002343417A1 (en) Novel nucleic acids and polypeptides
AU2001241511A1 (en) Novel nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
WO2002016439A8 (en) Novel nucleic acids and polypeptides